title: Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.
abstract: Epinephrine (E) and sympathetic nerve stimulation were described by Thomas Renton Elliott in 1905 for the first time. Dopamine (DA), norepinephrine (NE), E, and serotonin (5-HT) belong to the classic biogenic amines (or monoamines). Parkinson's disease (PD) is among the diseases in which it has been established that catecholamines may account for the neurodegeneration of central and peripheral catecholamine neural systems. PD is a chronic and progressive neurological disorder characterized by resting tremor, rigidity, and bradykinesia, affecting 2% of individuals above the age of 65 years. This disorder is a result of degeneration of DA-producing neurons of the substantia nigra and a significant loss of noradrenergic neurons in the locus coeruleus. In PD and other related neurodegerative diseases, catecholamines play the role of endogenous neurotoxins. Catechol-O-methyltransferase (COMT) and/or monoamine oxidase (MAO) catalyze the metabolism of monoamines. However, the monoamine transporters for DA, NE, and 5-HT namely DAT, NET, and SERT, respectively regulate the monoamine concentration. The metabolism of catecholamines and 5-HT involves common factors. Monoamine transporters represent targets for many pharmacological agents that affect brain function, including psychostimulators and antidepressants. In PD, polymorphisms of the COMT, MAO, DAT, NET, and 5- HTT genes may change the levels of biogenic amines and their metabolic products. The currently available therapies for PD improve the symptoms but do not halt the progression of the disease. The most effective treatment for PD patients is therapy with L-dopa. Combined therapy for PD involves a DA agonist and decarboxylase, MAOs and COMT inhibitors, and is the current optimal form of PD treatment maintaining monoamine balance.
authors.affiliation: Laboratory of Neurobiology, Department of Neurology.
authors.forename: Jolanta
authors.initials: J
authors.lastname: Dorszewska
authors.affiliation: Laboratory of Neurobiology, Department of Neurology.
authors.forename: Michal
authors.initials: M
authors.lastname: Prendecki
authors.affiliation: Laboratory of Neurobiology, Department of Neurology.
authors.forename: Anna
authors.initials: A
authors.lastname: Oczkowska
authors.affiliation: Department of Biochemistry and Molecular Biology.
authors.forename: Agata
authors.initials: A
authors.lastname: Rozycka
authors.affiliation: Department of Biochemistry and Molecular Biology.
authors.forename: Margarita
authors.initials: M
authors.lastname: Lianeri
authors.affiliation: Chair and Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
authors.forename: Wojciech
authors.initials: W
authors.lastname: Kozubski
keywords: COMT; MAO; Monoamine transporters polymorphism; PD.